Home / Food recalls / 2023
ActiPharma, Inc.
FDA recall F-0463-2024 · Class III · reported 2023-11-29 · Terminated
- Product
- ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.
- Reason
- FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.
- Quantity
- 607 bottles of 100 tablets each
- Distribution
- Domestic distribution, in Puerto Rico.
- Firm location
- PR, United States
- Initiated
- Voluntary: Firm initiated
- First notice
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
- Recall started
- 2023-09-28
- Terminated
- 2024-01-16
- Code info
- Lot 13309, Exp: 01/26
Source: U.S. Food and Drug Administration, openFDA Food Enforcement database (openFDA Food Enforcement, imported 2026-09). The FDA does not validate openFDA data for completeness or accuracy. This is a record of an enforcement action, not safety advice.